Successful Scale-up and Facility Expansion for Genomic Medicine (free seminar by Pall)

Short description

This seminar given by our partner Pall, will address the current manufacturing challenges faced by the industry and offer potential solutions. Choosing the right technologies capable of producing the required amount of virus or mRNA at the right quality is more important than ever.

Pall’s automated, end-to-end integrated platform solution coupled with our AcceleratorSM process development services (PDS) offers a holistic approach designed to decease risk, reduce costs and help speed you to market for your viral vector or mRNA manufacturing.

Preliminary Agenda:

09:30 – 10:00  Registration and coffee

10:00 – 10:10  Biotech Training Facility introduction

10.10 – 10.40  Viral vectors manufacturing: methods and challenges Presented by PALL

11.10 – 12.15  End-to-End Downstream Processing, including Mustang® Q membrane chromatography devices for full/empty capsid removal  Presented by PALL

12:15 – 13:30  Networking lunch

13:30 – 13:50   Pall mRNA capabilities Presented by PALL

13.50 – 14.30  Lipid nano vesicles capabilities and reproducible scale-up of mRNA Lipid Nanoparticles with NxGen disruptive technology Presented by Precision NanoSystems Inc.

14.30 – 15.30  Successful Scale-Up of a High Yielding Viral Vector Platform to 500 L using DoE approach Presented by PALL and Andelyn Biosciences

15:30 – 16:30  Equipment demonstration: Allegro™ STR 200 bioreactor / iCELLis® Nano / LevMixer® System/ Stax™/ Allegro™ MVP Single-Use System

16:30 –   Networking drinks

Objectives

•Meet the experts at Biotech Training Facility
•Discover scalable single-use technologies
•Learn about our PDS capabilities
•Hear case studies from end-users